Clinical Trials Logo

Sclerosis clinical trials

View clinical trials related to Sclerosis.

Filter by:

NCT ID: NCT05697523 Completed - Multiple Sclerosis Clinical Trials

Multiple Sclerosis and Respiratory and Functional Capacity

Start date: January 1, 2020
Phase:
Study type: Observational [Patient Registry]

It is known that respiratory functions, physical activities and functional capacities of Multiple Sclerosis (MS) patients decrease with the progression of the disease. However, there is not enough information about the severity of the effects of these parameters in mild Relapsing-Remitting Multiple Sclerosis (RRMS) patients. Our aim in this study is to compare the respiratory functions, physical activities and functional capacities of mild RRMS patients with healthy controls and to examine the relationship between them.

NCT ID: NCT05684016 Completed - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

NeuroQuant
Start date: December 2013
Phase: N/A
Study type: Interventional

The purpose of the research study is to investigate whether the extent and severity of lesions in the brain as measured by special MRI techniques can distinguish between Multiple Sclerosis (MS) patients with or without memory impairment and also between MS patients and age matched healthy controls.

NCT ID: NCT05682963 Completed - Multiple Sclerosis Clinical Trials

Efficacy of Square- Stepping Exercises in Individuals With Multiple Sclerosis

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

Square stepping exercises can promote correct foot placement, fast and coordinated step patterns, and sensory-motor interaction. The aim of this study is to examine the effect of square stepping exercises on mobility, balance and knee joint position sense in individuals with multiple sclerosis.

NCT ID: NCT05671055 Completed - Multiple Sclerosis Clinical Trials

CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis

Start date: January 7, 2023
Phase:
Study type: Observational

The present study will investigate the correlation between objective and subjective cognition in multiple sclerosis. The study will also investigate the impact of covariates such as fatigue and depression, the relationship with the Expanded Disability Status Scale (EDSS) and brain volumetrics as measured on magnetic resonance imaging (MRI). Additionally, the study will provide insights into patients' experiences with cognition, and the usability of the used objective cognitive assessments.

NCT ID: NCT05663853 Completed - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Start date: March 28, 2023
Phase:
Study type: Observational

All males and females between 18-70 years of age regardless of their race and ethnicity with a confirmed diagnosis of Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), and Relapse Remitting Multiple Sclerosis (RRMS) are invited to participate in this Observational study being conducted across four sites in the US. Since this is an observational study no medication/drug or treatment will be given to the participants. The investigator will be collecting information about the participant's MS disease, its progression, current medications, radiographic scans, and blood samples. This will help the investigator evaluate the biomarkers and new treatment options to better understand the MS disease process.

NCT ID: NCT05641714 Completed - Multiple Sclerosis Clinical Trials

The Reliability and Validity of the L-test in Patients With Multiple Sclerosis

Start date: December 15, 2022
Phase:
Study type: Observational

Walking safely inside or outside is an important function in patients with Multiple Sclerosis (PwMS) that affects their daily life activity and participation. Loss of functional mobility is the major component of walking disorders in PwMS. Therefore, it is important to evaluate functional mobility. Many functional mobility tests have been used for PwMS; however, these tests generally focus on walking speed and endurance. On the other hand, the L test, a variation of the timed up and go test (TUG), is a functional mobility measurement tool that extends the total walking distance to 20 meters and also requires the patients to turn both clockwise and counterclockwise. Although L the test is an easy-to-use, short-term test method that evaluates higher-level components of functional mobility such as turns and transfers, to our knowledge, no study has systematically examined the reliability and validity of the L test in PwMS yet. In addition, the cut-off times that best discriminate PwMS from healthy people and fallers with non-fallers with Multiple Sclerosis (MS) have not been reported. Therefore, this study planned to investigate the reliability, validity, and discrimination of the L test in PwMS.

NCT ID: NCT05641532 Completed - Clinical trials for Multiple Sclerosis (MS)

Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis

Start date: January 17, 2023
Phase: N/A
Study type: Interventional

This single group pre-post pilot intervention will examine the feasibility and initial effect of a 12-week behavioral intervention, based on the Behavior Change Wheel and Capability-Opportunity-Motivation-Behavior (COM-B) model and remotely delivered through electronic newsletters and online one-on-one video conferencing, for promoting physical activity and secondarily reducing fatigue and quality of life in persons newly diagnosed with MS (diagnosed with MS within the past 2 years). The investigators hypothesize the proposed 12-week intervention will be feasible based on process, resource, management, and scientific outcomes. The investigators further hypothesize that individuals who receive the 12-week intervention will demonstrate an increase in physical activity behavior, particularly daily step counts, and reduce fatigue.

NCT ID: NCT05635890 Completed - Clinical trials for Vestibular Rehabilitation in MS

Effect of Vestibular Rehabilitation on Trunk Kinetic and Kinematic Parameters in Patients With Multiple Sclerosis

Start date: May 6, 2022
Phase: N/A
Study type: Interventional

The Cawthorne Cooksey exercises and conventional program of physical therapy were administered.

NCT ID: NCT05627271 Completed - Multiple Sclerosis Clinical Trials

The 'Wearing Off' Effect of DMT

Start date: January 10, 2023
Phase:
Study type: Observational

This is a non-interventional, cross-sectional, qualitative study in which patients diagnosed with MS and clinicians with experience treating MS will be interviewed regarding patient experiences with the wearing off effect from ocrelizumab, natalizumab, and ofatumumab

NCT ID: NCT05604092 Completed - Clinical trials for Relapsing Remitting Multiple Sclerosis

Lesion Load and Location in Relation to Cognition, Fatigue and Physical Disability in RRMS

Start date: March 1, 2022
Phase:
Study type: Observational

In relapsing remitting multiple sclerosis (RRMS) the relationship between cognitive impairment (CI), fatigue and physical disability with white matter lesion load (WM-LL), location among other volumetric measures using automated platforms is still unclear.